An advisory panel of experts to the U.S. drug regulator will meet in June to review requests from Pfizer Inc and Moderna Inc for use of their COVID-19 vaccines in young children, the U.S. Food and Drug Administration said on Friday.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,